Related by context. All words. (Click for frequent words.) 63 β blockers 60 statins cholesterol lowering 59 QTc prolongation 59 thromboembolic disease 59 tumor histology 59 antidepressants SSRIs 58 serum lipid 58 postoperative AF 58 antioxidant supplementation 58 pharmacological therapy 58 thiopurine 58 dietary modification 57 intensive statin therapy 57 stone formers 57 residual confounding 57 glycosylated hemoglobin HbA1c 57 genes CYP#C# 57 plasma lipid 57 pharmacokinetic interactions 56 probiotic supplementation 56 hyperhomocysteinemia 56 serum creatinine levels 56 antiemetics 56 somatostatin analogs 56 RISPERDAL ® 56 cerebral vasospasm 56 selenium supplementation 56 myopathy rhabdomyolysis 56 synthetic progestin 56 prostaglandin analogues 56 adiponectin levels 56 Hypotension 56 sotalol 55 lipid parameters 55 metabolic parameters 55 pravastatin Pravachol 55 macrovascular events 55 impair fertility 55 pentoxifylline 55 lowering blood glucose 55 colorectal adenoma 55 neuropsychiatric symptoms 55 abnormal glucose tolerance 55 anticholinergic agents 55 Drospirenone 55 postprandial glycemia 55 plasma lipids 55 antihypertensive therapy 55 Bisphosphonate 55 prospective multicentre 55 APTIVUS r 55 cardio metabolic 54 torsade de pointes 54 nonnucleoside reverse transcriptase inhibitors 54 T2DM 54 HDL cholesterol triglycerides 54 hepatic insufficiency 54 unmeasured confounders 54 IGRAs 54 macrolide antibiotics 54 CVD mortality 54 TDF FTC 54 antithrombotic therapy 54 hematological parameters 54 HbA1C levels 54 ALI ARDS 54 serum BDNF 54 LRP5 54 MEVACOR 54 inflammatory biomarkers 54 endometrial hyperplasia 54 serum leptin 54 antiepileptics 54 erlotinib Tarceva 54 lipid elevations 54 tiagabine 54 vitamin D inadequacy 54 macrovascular disease 54 Heritability 53 colorectal carcinogenesis 53 EFFEXOR XR 53 CYP#D# inhibitor 53 concomitant medications 53 serum parathyroid hormone 53 prostate carcinogenesis 53 tardive dyskinesia TD 53 stratifying patients 53 microvascular disease 53 gastrointestinal GI bleeding 53 artery stenosis 53 albumin excretion 53 nonadherence 53 INVEGA ™ 53 HIV HCV coinfected 53 Meta analyzes 53 CYP#C# gene 53 Febrile neutropenia 53 electrophysiologic 53 postmenopausal estrogen 53 reblockage 53 familial clustering 53 bile acid metabolism 53 antidiabetic medications 53 Nocturia 53 coadministration 53 abdominal adiposity 53 HIV tropism 53 PHPT 53 potassium sparing diuretics 53 etiologic 53 impaired glucose metabolism 53 antiandrogen 53 prolonged QT interval 53 abnormal lipid 53 QTc intervals 53 atopic disease 53 non pharmacological interventions 53 abnormal lipid levels 53 Aortic stenosis 53 tipranavir ritonavir 53 symptom exacerbation 53 lipid abnormalities 53 androgen deficiency 53 alpha interferons 53 stavudine d4T 52 neutropenic 52 plasma homocysteine 52 arterial calcification 52 virologic failure 52 haloperidol Haldol 52 gastric cardia 52 lipid accumulation 52 Subgroup analyzes 52 serum HBV DNA 52 Pramlintide 52 arterial thickening 52 imatinib resistance 52 BEXXAR Therapeutic Regimen 52 candidemia 52 diabetic kidney 52 suboptimal adherence 52 EGFR tyrosine kinase inhibitors 52 antiplatelet medications 52 haematologic 52 Hydroxyurea 52 intima media thickness IMT 52 HER2 overexpression 52 H. pylori eradication 52 postmenopausal hormone 52 chlamydial infection 52 cardiac repolarization 52 distensibility 52 intestinal motility 52 nitrofurantoin 52 ERK signaling 52 Calcium intake 52 lichen planus 52 OSAHS 52 hyperparathyroidism 52 follicular lymphoma FL 52 postmenopausal hormone replacement 52 Prostatitis 52 topical calcineurin inhibitors 52 IDDM 52 nonhematologic adverse reactions 52 Cardiotoxicity 52 nonalcoholic steatohepatitis NASH 52 K ras mutations 52 systemic corticosteroid 52 omeprazole Prilosec 52 meta regression 52 unmeasured factors 52 aromatase inhibitors AIs 52 prognostic indicators 51 proguanil 51 Cognitive impairment 51 IL6 51 Tasigna prolongs 51 airway hyperresponsiveness 51 venous thromboembolic disease 51 pressure natriuresis 51 efalizumab 51 pleiotropic effects 51 p# activation 51 unfavorable cytogenetics 51 carotid bruit 51 hypertension diabetes mellitus 51 bivariate analyzes 51 clinicopathological 51 Genetic variants 51 intranasal corticosteroids 51 haemodynamic 51 bone metabolism 51 conditional logistic regression 51 GH deficiency 51 fluoroquinolone resistance 51 estrogen metabolism 51 immunosuppressive agents 51 underlying pathophysiology 51 neurosensory 51 trials RCTs 51 Prilosec omeprazole 51 VEGF inhibitors 51 LDL cholesterol concentrations 51 HER2 positivity 51 exploratory endpoints 51 potentially modifiable 51 VKORC1 51 diabetic dyslipidemia 51 antidepressants fluoxetine 51 topical NSAIDs 51 autonomic dysfunction 51 pharmacodynamic parameters 51 velafermin 51 intestinal permeability 51 neurocognitive functioning 51 AGILECT R 51 Hepatotoxicity 51 GnRH agonists 51 prognostic variables 51 thalidomide Thalomid 51 prospectively stratified 51 Allergic asthma 51 elevated IOP 51 atherothrombotic 51 HF ACTION 51 psychopharmacologic 51 Secondary efficacy endpoints 51 AZT zidovudine 51 postoperative atrial fibrillation 51 multivariate Cox 51 fetal malformations 51 generalisability 51 trastuzumab Herceptin ® 51 suppressive therapy 51 genetic polymorphisms 51 leukocyte counts 51 MAGE A3 ASCI 51 sitagliptin Januvia 51 Protease Inhibitors 51 macrovascular complications 51 SUSTENNA TM 51 Liver toxicity 51 antiretroviral naive 51 Venous thromboembolism 51 atherothrombotic disease 51 griseofulvin 51 androgen depletion 51 nonfasting triglyceride levels 51 gonococcal 51 neurocognitive impairment 51 oral hypoglycemic agents 51 modifiable lifestyle 50 orofacial clefts 50 genital herpes infections 50 nucleoside analogs 50 immunosuppressive therapies 50 multivariable analysis 50 univariate analyzes 50 bortezomib Velcade 50 APOE genotype 50 surrogate markers 50 dysglycemia 50 ALT flares 50 blood lipid profiles 50 EEG abnormalities 50 multivitamin supplementation 50 central adiposity 50 serum cortisol 50 KCNH2 50 diabetes dyslipidemia 50 nonvaccine 50 HIF 1a 50 #beta HSD1 50 etiologic factors 50 antiestrogen 50 serum PTH 50 carotid atherosclerosis 50 Peripheral arterial disease 50 FGFs 50 mitochondrial metabolism 50 urate lowering 50 Glucocorticoids 50 MDRD 50 osteosarcomas 50 leukotriene receptor antagonist 50 S. aureus isolates 50 nonalcoholic steatohepatitis 50 Hypercholesterolemia 50 Genetic predisposition 50 ritonavir boosted 50 avosentan 50 dyssynchrony 50 Socioeconomic status 50 NNRTIs 50 aortic regurgitation 50 T2 lesions 50 monogenic 50 G6PD deficiency 50 GST pi 50 endogenous estrogen 50 recurrent genital herpes 50 Gilead Viread 50 etiological 50 endogenous hormones 50 sociodemographic characteristics 50 ketogenic diets 50 PYY #-# 50 psychosocial variables 50 serum phosphorous 50 K ras gene 50 loop diuretic 50 nongenetic 50 Lowering cholesterol 50 cardiovascular disease hypertension 50 containing abacavir 50 Sipuleucel T 50 Elevated triglycerides 50 cervicitis 50 amisulpride 50 comorbid depression 50 pharmacodynamic markers 50 reverse transcriptase inhibitors 50 torsemide ER 50 evaluating tivozanib 50 nevirapine Viramune 50 Known generically 50 APTIVUS 50 dopaminergic therapy 50 metabolic abnormalities 50 hypovitaminosis D 50 PKC inhibitors 50 tumor subtypes 50 Symadex 50 MS relapses 50 AML MDS 50 antimetabolites 50 varenicline Chantix 50 LAB CGRP 50 serum calcium levels 50 Cholinesterase Inhibitors 50 Helicobacter pylori eradication 50 premorbid 49 metaanalysis 49 bronchial hyperresponsiveness 49 anti dyslipidemic 49 untreated OSA 49 pharmacologic treatments 49 CYP#A# substrates 49 PKC beta 49 gemifloxacin 49 cardiac biomarkers 49 overt nephropathy 49 nucleoside analogues 49 indinavir Crixivan 49 CP CPPS 49 atheroma volume 49 serum biomarkers 49 surgical prophylaxis 49 hydrolyzed formula 49 covariate 49 mammographic density 49 CYP#A# CYP#D# 49 Serdolect ® 49 LYSTEDA 49 AZT zidovudine Retrovir 49 epistasis 49 CHD mortality 49 CYT# potent vascular disrupting 49 chronic prostatitis chronic 49 histologic subtypes 49 intra abdominal abscess 49 differential gene expression 49 antiapoptotic 49 carotid artery blockage 49 NHANES III 49 panitumumab Vectibix 49 TWYNSTA 49 Vitamin D insufficiency 49 dietary antioxidants 49 remnant lipoproteins 49 Genetic variation 49 Yohimbine 49 Nuvigil armodafinil 49 noncardiovascular 49 Ischemic 49 progestin therapy 49 PON1 gene 49 lamivudine 3TC 49 VT VF 49 STEP BD 49 alexithymia 49 artemisinins 49 urolithiasis 49 Dyslipidemia 49 antiplatelet therapies 49 socioeconomic status SES 49 Achieves Primary Endpoint 49 genetic determinants 49 virologic responses 49 convergent validity 49 autoantibody levels 49 aminotransferase 49 abnormal glucose metabolism 49 vulvovaginal atrophy 49 commonly prescribed antidepressants 49 visceral adiposity 49 multidrug regimens 49 androgen excess 49 antenatal depression 49 hematologic parameters 49 Chronic insomnia 49 empiric therapy 49 nonsignificant trend 49 acamprosate calcium 49 HCV replication 49 Sustiva efavirenz 49 Oxidative damage 49 echocardiographic parameters 49 stepwise logistic regression 49 cardiovascular calcification 49 olanzapine quetiapine 49 Erythropoietic therapies may 49 uric acid lowering 49 physiologic mechanisms 49 sargramostim 49 elevated fasting glucose 49 adipogenic 49 insulin resistance syndrome 49 Fibroblast growth 49 immunosuppressant therapy 49 multiple logistic regression 49 Symptom severity 49 herpes zoster vaccine 48 induce orthostatic hypotension 48 postexposure prophylaxis 48 relate thereto 48 clade B 48 gefitinib Iressa 48 Hematologic 48 SPRYCEL ® 48 efavirenz Sustiva 48 hypereosinophilic syndrome 48 Cholesterol Levels SPARCL 48 MTHFD1L gene 48 genetic polymorphism 48 CINQUIL 48 atherosclerotic coronary 48 lipoprotein profiles 48 thyroid carcinoma 48 telomere lengths 48 1 diabetes T1D 48 Combination antiretroviral therapy 48 generalisable 48 transgene expression 48 somatoform disorders 48 EGFR inhibitors 48 confounding variables 48 Mindfulness Based Cognitive Therapy 48 anemia neutropenia 48 headache abdominal pain 48 Levaquin levofloxacin 48 metaplasia 48 Observational studies 48 intensive lipid lowering 48 Isentress raltegravir 48 vitamin B1 deficiency 48 Protease inhibitor 48 irregular menses 48 arterial stiffening 48 EBV infection 48 obesity insulin resistance 48 daytime drowsiness 48 causal pathway 48 benign thyroid nodules 48 impaired cognition 48 impaired insulin secretion 48 Afib 48 methodologic 48 hepatic cirrhosis 48 diabetic retinopathy DR 48 glycaemia 48 thyroid hormone levels 48 sirtuin activators 48 cartilage degeneration 48 Multivariate logistic regression 48 decompensated cirrhosis 48 See CLINICAL PHARMACOLOGY 48 confounder 48 gastric carcinoma 48 Warfarin Coumadin 48 cytogenetic abnormalities 48 Kivexa 48 psychiatric comorbidity 48 multivariate analyzes 48 triple nucleoside 48 transthyretin amyloidosis 48 receiving XGEVA 48 hepatitis B immunoglobulin 48 EXJADE 48 glucose abnormalities 48 hormonal abnormalities 48 severe periodontitis 48 Daptomycin 48 adrenal hormone 48 binary restenosis 48 ritonavir boosted protease inhibitor 48 pharmacotherapies 48 Lipodystrophy 48 Transdermal Delivery 48 CYP#A# substrate 48 atovaquone 48 ± SEM 48 Genetic variations 48 Brugada syndrome 48 Treg cell 48 Thalomid ® 48 INTELENCE 48 serum phosphate 48 Fibroblast 48 antiretroviral naïve 48 coinfection 48 poststroke depression 48 acute mania 48 Mantel Haenszel 48 heritable variation 48 androgen therapy 48 physico chemical properties 48 intracellular signal transduction 48 therapeutic regimens 47 nociceptive pain 47 atherothrombosis 47 Celsentri Selzentry 47 multidrug 47 comorbid psychiatric disorders 47 genotypic resistance 47 FRAGMIN 47 demonstrated clinically meaningful 47 mania hypomania 47 Thyroid disorders 47 CETP gene 47 Exacerbations 47 HF hospitalization 47 Socioeconomic factors 47 nucleotide analog 47 erythema nodosum 47 PI3K signaling 47 indications contraindications 47 myelofibrosis polycythemia vera 47 psychopharmacological 47 unmeasured confounding 47 newer antipsychotic medications 47 Genetic Variation 47 Chlamydia trachomatis infection 47 dentinal hypersensitivity 47 rituximab Rituxan 47 familial predisposition 47 slow metabolizers 47 pathophysiologic 47 hematopoietic malignancies 47 protein tyrosine phosphatase 1B 47 pulmonary exacerbations 47 chemoprevention trials 47 diabetic microvascular complications 47 endometrial carcinoma 47 GABRA2 gene 47 serum cotinine levels 47 vascular dysfunction 47 Premature menopause 47 anatomical abnormalities 47 γ secretase 47 Hypertrophy 47 multivariate logistic regression 47 Allergic Rhinitis 47 Plasmodium infection 47 obstructive CAD 47 conivaptan 47 hereditary predisposition 47 biochemical imbalances 47 somnolence sleepiness 47 multivariable adjustment 47 allergic sensitization 47 MYH9 47 inattention hyperactivity 47 Deforolimus 47 Adverse effects 47 dermatologic reactions 47 lipoprotein metabolism 47 NSABP C 47 BCR ABL inhibitor 47 metabolic syndrome MetS 47 cross sectionally 47 cAMP signaling 47 circulating endothelial cells 47 neurosurgical clipping 47 abrupt discontinuation 47 serologically active patients 47 intracranial stenosis 47 polygenic 47 drug metabolizing enzyme 47 genetic susceptibilities 47 Multiple logistic regression 47 ovulatory cycles 47 Polyp Prevention Trial 47 Fludara ® 47 psychosocial stressors 47 Dose Response 47 metabolic dysregulation 47 Glycopyrrolate 47 Blepharospasm 47 Subtypes 47 metabolizing enzymes 47 triple nucleoside regimen 47 #q# deletion 47 allograft rejection 47 cortical excitability 47 Multidrug 47 Uncontrolled hypertension 47 recurrent ischemic 47 Alequel 47 viral kinetics 47 Excessive daytime sleepiness 47 CYP#D# gene 47 CALHM1 47 Zemplar Capsules 47 aplindore 47 predisposing factors 47 Sprycel dasatinib 47 CYP#A# gene 47 meta analytic 47 clinicopathologic 47 mild hepatic impairment 47 COX enzymes 47 relapsed MM 47 serum bicarbonate 47 sociodemographic factors 46 HMGCR 46 spirometric 46 CanAg 46 antihormonal 46 doxorubicin Adriamycin 46 NRF2 gene 46 JAK2 enzyme 46 INCB# [001] 46 mitral stenosis 46 crizotinib PF # 46 PI3K AKT 46 cMET 46 multiplicative 46 AT1R 46 juvenile idiopathic arthritis 46 Suicidality 46 gonococcal infections 46 nausea vomiting headache 46 chemosensitivity 46 APOE e4 gene 46 papillary renal cell carcinoma 46 Treating Chronic 46 apnea hypopnea 46 Thromboembolic 46 comorbid conditions 46 dietary patterns 46 ABCB1 gene 46 polyarticular 46 neuronal plasticity 46 causal pathways 46 airway narrowing 46 pathophysiological mechanisms 46 tumor subtype 46 atheromatous 46 BCL#A 46 prospective observational studies 46 infarcted myocardium 46 multifactorial 46 fatigue diarrhea nausea 46 origin PNH 46 Thiovir 46 Cryptococcus neoformans 46 adamantanes 46 protein tyrosine phosphatases 46 hyperemia 46 externalizing behaviors 46 atherosclerosis thickening 46 headache nausea diarrhea 46 Akt inhibitor 46 Myelodysplastic syndromes MDS 46 fibrosis progression 46 obesity sedentary lifestyle 46 dyskinesias 46 perfusion MRI 46 telogen effluvium 46 Dr. Edward Giovannucci 46 atopic sensitization 46 gene loci 46 thyroid hormone deficiency 46 inherited mutations 46 pharmacogenetic testing 46 cell adhesion molecules 46 Relapsing remitting MS 46 Prediabetes 46 slow progressors 46 spontaneous regression 46 pleiotropic 46 DNA hypermethylation 46 venules 46 Personality traits 46 Cardiopulmonary bypass 46 capillary leakage 46 Postmarketing 46 #q# deletion syndrome 46 periodontal diseases 46 GBA mutations 46 modifiable risk 46 Apoptone 46 mechanistic studies 46 meningiomas 46 alefacept 46 BARACLUDE ® 46 narrowings 46 acute respiratory tract infections 46 internalizing disorders 46 CYP#D# genotype 46 BRCA1 BRCA2 46 Androgenetic alopecia 46 gonadal hormones 46 affective psychosis 46 Cardiorespiratory fitness 46 3TC lamivudine Epivir 46 H. pylori infections 45 pigmentary 45 unfavorable prognostic 45 hypertension hypercholesterolemia 45 logistic regression model 45 immune reconstitution syndrome 45 adipokines 45 limiting generalizability 45 Neurogenic Orthostatic Hypotension 45 BARACLUDE R 45 Abdominal fat 45 glial tumors 45 subclinical disease 45 immune dysregulation 45 Serum calcium 45 obstructive coronary 45 metabolic abnormality 45 baseline A1C 45 bivariate 45 glycogen metabolism 45 mean ± SEM 45 Atopic dermatitis 45 antidepression drugs 45 generalized seizures 45 DNA methylation patterns 45 functional gastrointestinal disorders 45 T. vaginalis 45 KDOQI 45 Vaxfectin R 45 HRCT 45 Virologic 45 proliferative retinopathy 45 eosinophilic pneumonia 45 perinatal outcomes 45 kidney urologic 45 aetiological 45 Daytime sleepiness 45 arteriosclerosis hardening 45 Dysregulation 45 Myriad Flurizan 45 Anthracycline 45 mycosis fungoides 45 Pharmacologic 45 EMPOWER TM 45 biologic DMARDs 45 MenACWY 45 Antitumor Activity 45 arteriosclerotic 45 comorbidities 45 Yaemsiri wanted 45 d l leucovorin 45 Clusterin 45 neuro psychiatric disorders 45 inherit predisposition 45 stenotic 45 EGFR inhibition 45 androgenic hormones 45 antituberculosis 45 buprenorphine naloxone 45 gallium nitrate 45 etiological factors 45 bone marrow fibrosis 45 inherited genetic mutations 45 Tumor Response 45 HSCT 45 frequent awakenings 45 biologic pathways 45 protease inhibitors PIs 45 sJIA 45 methodological weaknesses 45 bacterial virulence 45 multi factorial disease 45 comorbid disorders 45 compulsive hoarding syndrome 45 chronicity 45 interferon ribavirin 45 dyskeratosis congenita 45 L. donovani 45 rhinovirus infection 44 comorbid illnesses 44 Wisconsin Sleep Cohort 44 Endocrine Therapy 44 arterial plaque buildup 44 arteriolar 44 pleiotropy 44 explanatory variables 44 streptococcal pharyngitis 44 macular edema 44 sociodemographic variables 44 brain neurochemistry 44 Dental caries 44 Antitumor 44 left ventricular diastolic 44 Atripla combines 44 P. falciparum parasites 44 R entecavir 44 daytime somnolence 44 Nicotine dependence 44 ventricular hypertrophy 44 atherosclerosis narrowing 44 TXNIP 44 Logistic regression 44 erythropoietic agents 44 oral mTOR inhibitor 44 #T# L1 44 DNA hypomethylation 44 HIV RNA 44 co morbidities 44 neuropsychological deficits 44 lens opacities 44 microbiologic 44 favorable pharmacokinetic profile 44 metabolic syndromes 44 foodborne infections 44 lowering uric acid 44 tic severity 44 pemetrexed Alimta 44 oestrogens 44 tamoxifen Nolvadex ® 44 heterologous expression 44 shorten telomeres 44 neuronal nicotinic receptor NNR 44 miRNA expression 44 multisystemic 44 Abdominal obesity 44 asymptomatic hyperuricemia 44 carbohydrate polymers 44 Catheter Associated 44 distal colon 44 chemically alters 44 urate oxidase 44 reclog 44 impulsive behaviors 44 subthalamic 44 socioeconomic deprivation 44 dentin hypersensitivity 44 underdiagnosis 44 cardiac arrhythmia abnormal 44 PCOD 44 interindividual variability 44 Therein lurks 44 genetic loci 44 nonbacterial prostatitis 44 Mutational 44 P cadherin 44 comorbid psychiatric 44 confounders 44 aneuploid cells 44 AUDs 44 Thyroid nodules 44 ixabepilone 44 Immunotherapeutic 44 Female Athlete Triad 44 REYATAZ ® 44 amyloid formation 44 anti Parkinsonian 44 inherited predisposition 44 zoledronic acid Reclast 44 glycopeptides 44 obstructive sleep apnea hypopnea 44 SpHb monitoring 44 Demonstrates Positive 44 gene rearrangements 44 eliglustat tartrate 44 Comorbid 44 Septic Shock 44 author Xiang Gao 44 MLH1 44 Newly Diagnosed Multiple Myeloma 44 Sugar sweetened beverages 43 primary ovarian insufficiency 43 Excessive Sleepiness 43 bifurcated lesions 43 vascular endothelial dysfunction 43 vitamin B# folic acid 43 Pseudomonas aeruginosa infections 43 multivariate regression analysis 43 CIPN 43 PLMs 43 methodological shortcomings 43 Synovial sarcoma 43 Mood disorders 43 pathophysiological processes 43 Triapine 43 neonatal morbidity 43 Pernicious anemia 43 MMP9 43 blood clots thrombosis 43 epigenetic therapies 43 Disordered eating 43 Generalised Anxiety Disorder 43 bispectral index BIS 43 chronic acid reflux 43 Diastolic pressure 43 causative pathogens 43 presymptomatic 43 menstrual irregularities 43 fatty plaque buildup 43 carbohydrate metabolism 43 H#K#me# 43 aqueous outflow 43 Imprinted genes 43 tumor necrosis 43 cytokines chemokines 43 oncogene addiction 43 Gag polymorphisms 43 placental hormones 43 AVONEX PEN 43 fatty infiltration 43 endocrine therapies 43 CARDIA study 43 Bcr Abl mutations 43 intracranial atherosclerosis 43 opacification 43 invasive angiography 43 molecular abnormalities 43 epigenetic mechanisms 43 BIM #A# 43 moderately heritable 43 Candida overgrowth 43 NHAMCS 43 Bruxism 43 inflammatory rheumatic 43 NRTI resistance 43 throat esophagus 43 Staph aureus infections 43 pulse amplitude 43 ponatinib 43 cardiac malformations 43 Hormonal imbalances 43 mg/m2 cohort 43 guanine nucleotide exchange 43 peri implant 43 asymptomatic carotid stenosis 43 intercellular communication 43 Pneumocystis carinii pneumonia 43 untreated hypothyroidism 43 STRATEGY FOR AN OPEN 43 drug metabolizing enzymes 43 Oral contraceptive 43 viral tropism 43 Drug eluting stent 43 refractive error 43 diabetes hypertension hyperlipidemia 43 nonhereditary 43 blocked carotid arteries 43 bortezomib refractory 43 PIK3CA 43 Cokkinides 43 geriatric syndromes 43 diameter stenosis 43 hypertrophic scarring 43 multifactorial disease 43 vulvovaginal candidiasis 43 evaluating mipomersen 43 CCR5 receptor antagonist 43 phase IIb trial 43 Sarcopenia 43 eczema asthma 43 acute subacute 43 GI perforation 43 ovarian endometrial 43 hormone imbalances 43 subfertility 43 IL#B 43 bronchopulmonary dysplasia BPD 43 Antibiotic resistant infections 43 pain syndromes 43 neurobiological basis 43 Genetic susceptibility 43 epididymal